Skip to main content
. Author manuscript; available in PMC: 2014 Nov 10.
Published in final edited form as: Biochem Biophys Res Commun. 2013 Jul 24;438(2):283–288. doi: 10.1016/j.bbrc.2013.07.056

Figure 1. Significantly decreased GABARAPL1 and GATE-16 expression in primary AML patient samples.

Figure 1

GABARAP (A), GABARAPL1 (B) and GATE-16 (C) mRNA levels of granulocytes from healthy donors, CD34+ progenitor cells and AML patient samples were quantified utilizing qPCR. The relative ∆Ct expression was calculated by the difference of GABARAP, GABARAPL1 and GATE-16 expression to the housekeeping genes HMBS and ABL. M.W.U, *p<0.01. **p<0.001, *** p<0.0001.